Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
ConditionMeningioma
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-89
SponsorWeill Medical College of Cornell University
About this trial
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
Eligibility criteria
Qualifiers
Adult patients with clinically suspected meningioma
Patients planned for surgery - undergoing preoperative workup
No contraindications to either radiotracer
Disqualifiers
Age less than 18 years
Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia.
Trial design
Treatments tested in this trial
- Ga-68- DOTATATE
- Ga-68-DOTATOC
Treatment groups
6 Participants
are divided into 1 treatment groupSponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
Cornell University
Collaborator
Source ClinicalTrials.gov